FI104499B - Erittäviä E. coli-kantoja - Google Patents

Erittäviä E. coli-kantoja Download PDF

Info

Publication number
FI104499B
FI104499B FI921874A FI921874A FI104499B FI 104499 B FI104499 B FI 104499B FI 921874 A FI921874 A FI 921874A FI 921874 A FI921874 A FI 921874A FI 104499 B FI104499 B FI 104499B
Authority
FI
Finland
Prior art keywords
protein
membrane
coli
proteins
antibody
Prior art date
Application number
FI921874A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI921874A0 (fi
FI921874A (fi
Inventor
Charles A Lunn
Satwant K Narula
Richard L Reim
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of FI921874A0 publication Critical patent/FI921874A0/fi
Publication of FI921874A publication Critical patent/FI921874A/fi
Application granted granted Critical
Publication of FI104499B publication Critical patent/FI104499B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244Interleukins [IL]
    • C07K16/247IL-4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245Escherichia (G)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • C07K14/5406IL-4
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/01Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/185Escherichia
    • C12R2001/19Escherichia coli

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI921874A 1989-10-31 1992-04-27 Erittäviä E. coli-kantoja FI104499B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8904788 1989-10-31
PCT/US1989/004788 WO1991006655A1 (en) 1989-10-31 1989-10-31 E. coli secretory strains

Publications (3)

Publication Number Publication Date
FI921874A0 FI921874A0 (fi) 1992-04-27
FI921874A FI921874A (fi) 1992-04-27
FI104499B true FI104499B (fi) 2000-02-15

Family

ID=22215324

Family Applications (1)

Application Number Title Priority Date Filing Date
FI921874A FI104499B (fi) 1989-10-31 1992-04-27 Erittäviä E. coli-kantoja

Country Status (10)

Country Link
EP (1) EP0497757B1 (ja)
JP (1) JP2660095B2 (ja)
KR (1) KR960013134B1 (ja)
AU (1) AU651059B2 (ja)
DE (1) DE68916444T2 (ja)
FI (1) FI104499B (ja)
HK (1) HK185296A (ja)
HU (1) HU214828B (ja)
NO (1) NO305253B1 (ja)
WO (1) WO1991006655A1 (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9203753D0 (sv) * 1992-12-11 1992-12-11 Kabi Pharmacia Ab Expression system for producing apolipoprotein ai-m
US5716612A (en) * 1994-09-07 1998-02-10 Schering Corporation Use of IL-4 for potentiation of chemotherapeutic agents
SE9500778D0 (sv) * 1995-03-03 1995-03-03 Pharmacia Ab Process for producing a protein
SE9603068D0 (sv) * 1996-08-23 1996-08-23 Pharmacia & Upjohn Ab Process for purifying a protein
SE9603303D0 (sv) 1996-09-11 1996-09-11 Pharmacia & Upjohn Ab Process for purifying a protein
DE19915938A1 (de) * 1999-04-09 2000-10-19 Aventis Pharma Gmbh Herstellung von pankreatischer Procarboxypeptidase B, Isoformen und Muteinen davon und ihre Verwendung
DE502006009060D1 (de) 2006-09-22 2011-04-21 Wacker Chemie Ag Verfahren zur fermentativen Herstellung von Antikörpern
CN109370936A (zh) * 2018-10-25 2019-02-22 中国人民解放军军事科学院军事医学研究院 一株广谱抗噬菌体的大肠埃希氏菌bl21(de3)-pr及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2634856A1 (de) * 1976-08-03 1978-02-09 Hoechst Ag Verfahren zur herstellung von schwefelsaeurehalbester-verbindungen
JPS5936981B2 (ja) * 1979-08-09 1984-09-06 住友化学工業株式会社 アミノアリ−ル−β−スルファ−トエチルスルホンの製造法
JPS5936982B2 (ja) * 1979-08-14 1984-09-06 住友化学工業株式会社 アミノアリ−ル−β−スルファ−トエチルスルホンの製造法
US4595658A (en) * 1982-09-13 1986-06-17 The Rockefeller University Method for facilitating externalization of proteins synthesized in bacteria
US4757013A (en) * 1983-07-25 1988-07-12 The Research Foundation Of State University Of New York Cloning vehicles for polypeptide expression in microbial hosts
DE3340114A1 (de) * 1983-11-05 1985-05-15 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von 2-amino-1-hydroxy-4- oder -5- (ss-sulfatoaethylsulfonyl)-benzol-verbindungen und deren verwendung zur synthese von faserreaktiven verbindungen
AU3006789A (en) * 1988-02-24 1989-08-24 Smithkline Beckman Corporation Expression of hiv binding proteins

Also Published As

Publication number Publication date
JPH04505548A (ja) 1992-10-01
FI921874A0 (fi) 1992-04-27
NO921674D0 (no) 1992-04-29
FI921874A (fi) 1992-04-27
DE68916444T2 (de) 1994-11-03
HK185296A (en) 1996-10-11
AU4644789A (en) 1991-05-31
AU651059B2 (en) 1994-07-14
WO1991006655A1 (en) 1991-05-16
HUT64597A (en) 1994-01-28
EP0497757B1 (en) 1994-06-22
NO305253B1 (no) 1999-04-26
DE68916444D1 (de) 1994-07-28
EP0497757A1 (en) 1992-08-12
JP2660095B2 (ja) 1997-10-08
KR960013134B1 (ko) 1996-09-30
HU9201411D0 (en) 1992-07-28
HU214828B (hu) 1998-06-29
NO921674L (no) 1992-06-29

Similar Documents

Publication Publication Date Title
Michaelis et al. Mutations that alter the signal sequence of alkaline phosphatase in Escherichia coli
JP2687995B2 (ja) Dna配列、組替えdna分子およびヒト繊維芽細胞インターフェロン様ポリペプチドの製造方法
Chen et al. High‐level accumulation of a recombinant antibody fragment in the periplasm of Escherichia coli requires a triple‐mutant (degP prc spr) host strain
US4595658A (en) Method for facilitating externalization of proteins synthesized in bacteria
US5292646A (en) Peptide and protein fusions to thioredoxin and thioredoxin-like molecules
US5578464A (en) E. coli secretory strains
Tittgen et al. Isolation of cDNA clones for fourteen nuclear-encoded thylakoid membrane proteins
EP1500665A1 (en) METHOD FOR CONSTRUCTING scDb LIBRARIES
SK280265B6 (sk) Vektor zahŕňajúci gén kódujúci bielkovinu gm-csf p
JPH03500008A (ja) 組み換え系におけるグルコースオキシダアーゼの産生
JPS62501607A (ja) 組換コロニ−刺激因子↓−1
JPH05507209A (ja) チオレドキシンおよびチオレドキシン様分子に対するペプチドおよび蛋白融合
JPH0838176A (ja) 改良組換dna分子
FI104499B (fi) Erittäviä E. coli-kantoja
JPH03505279A (ja) インターロイキン―1インヒビター
JPH082308B2 (ja) araBプロモーターを含有する複製可能な発現ビヒクル
CA1340091C (en) Enhanced protein production in bacteria by employing novel ribosome binding site
HU204888B (en) Process for producing dns sequences coding proteins, vectors, transformed host cells and proteins having biological effectivity of i type husi inhibitor, as well as pharmaceutical preparatives containing said agents
Sarthy et al. Use of gene fusions to determine a partial signal sequence of alkaline phosphatase
Ubbink et al. Cloning, sequencing and expression studies of the genes encoding amicyanin and the β‐subunit of methylamine dehydrogenase from Thiobacillus versutus
AU631107B2 (en) Polypeptides useful in diagnosis of coccidia infection and recombinant-dna methods for manufacturing same
US4935370A (en) Expression plasmids for improved production of heterologous protein in bacteria
DK175020B1 (da) Fremgangsåde til udtrykkelse og ekstracellulær udskillelse af proteiner i G(-)bakterie, rekombinant DNA-konstruktion og plasmidvektor kodende herfor, samt G(-)bakterie indeholdende disse
EP1678308B1 (en) Expression vector for secreting antibody fragment using e. coli signal sequence and method for mass-producing antibody fragment
JP4357116B2 (ja) 酵素活性組換えヒトβ−トリプターゼ及びその生産方法

Legal Events

Date Code Title Description
MA Patent expired